These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32862517)

  • 1. Corneal and scleral permeability of Desmoteplase in different species.
    Brütsch DR; Hunziker P; Pot S; Tappeiner C; Voelter K
    Vet Ophthalmol; 2020 Sep; 23(5):785-791. PubMed ID: 32862517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic Capacity of Desmoteplase Compared to Tissue Plasminogen Activator in Rabbit Eyes.
    Voelter K; Tappeiner C; Klein K; Borel N; Bruetsch D; Laguna Sanz F; Pot SA
    J Ocul Pharmacol Ther; 2019; 35(1):66-75. PubMed ID: 30376399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
    Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
    Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
    Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
    Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Examination of the Thrombolytic Efficacy of Desmoteplase and Therapeutic Ultrasound Compared with rt-PA.
    Roessler FC; Wang Z; Schumacher S; Ohlrich M; Kaps M; Menciassi A; Eggers J
    Ultrasound Med Biol; 2015 Dec; 41(12):3233-40. PubMed ID: 26349583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal and scleral permeability of quinolones--a pharmacokinetics study.
    Tai MC; Lu DW; Chiang CH
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):547-54. PubMed ID: 14733712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1.
    Dong N; Da Cunha V; Citkowicz A; Wu F; Vincelette J; Larsen B; Wang YX; Ruan C; Dole WP; Morser J; Wu Q; Pan J
    Thromb Haemost; 2004 Nov; 92(5):956-65. PubMed ID: 15543321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.
    Loch C; Zakelj S; Kristl A; Nagel S; Guthoff R; Weitschies W; Seidlitz A
    Eur J Pharm Sci; 2012 Aug; 47(1):131-8. PubMed ID: 22659372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
    Kruithof EK; Schleuning WD
    Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pranoprofen quantification in ex vivo corneal and scleral permeation samples: Analytical validation.
    Cañadas-Enrich C; Abrego G; Alvarado HL; Calpena-Campmany AC; Boix-Montañes A
    J Pharm Biomed Anal; 2018 Oct; 160():109-118. PubMed ID: 30077069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vampire bat plasminogen activator DSPA-alpha-1 (desmoteplase): a thrombolytic drug optimized by natural selection.
    Schleuning WD
    Haemostasis; 2001; 31(3-6):118-22. PubMed ID: 11910176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activators from the saliva of Desmodus rotundus (common vampire bat): unique fibrin specificity.
    Schleuning WD; Alagon A; Boidol W; Bringmann P; Petri T; Krätzschmar J; Haendler B; Langer G; Baldus B; Witt W
    Ann N Y Acad Sci; 1992 Dec; 667():395-403. PubMed ID: 1309059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.
    Edelhauser HF; Maren TH
    Arch Ophthalmol; 1988 Aug; 106(8):1110-5. PubMed ID: 3401140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoteplase in acute massive pulmonary thromboembolism.
    Tebbe U; Bramlage P; Graf A; Lechleitner P; Bode C; Riess FC; Clemens N; Al-Rawi Y; Konstantinides S; Goldhaber SZ
    Thromb Haemost; 2009 Mar; 101(3):557-62. PubMed ID: 19277420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clot Formation in the Presence of Acetylsalicylic Acid Leads to Increased Lysis Rates Regardless of the Chosen Thrombolysis Strategy.
    Roessler FC; Schumacher S; Sprenger A; Gärtner U; Al-Khaled M; Eggers J
    J Vasc Res; 2016; 53(3-4):128-137. PubMed ID: 27710967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
    Hämäläinen KM; Kananen K; Auriola S; Kontturi K; Urtti A
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):627-34. PubMed ID: 9071216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of desmoteplase-induced fibrinolytic activity in vitro.
    Hoffmann JJ; Kops O
    J Thromb Thrombolysis; 2005 Aug; 20(1):23-6. PubMed ID: 16133891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea.
    Ahmed I; Gokhale RD; Shah MV; Patton TF
    J Pharm Sci; 1987 Aug; 76(8):583-6. PubMed ID: 11002815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.